Arca
Skip to content
Tools
Tools

PTGS1: Prostaglandin G/H synthase 1

Dual cyclooxygenase and peroxidase that plays an important role in the biosynthesis pathway of prostanoids, a class of C20 oxylipins mainly derived from arachidonate ((5Z,8Z,11Z,14Z)- eicosatetraenoate, AA, C20:4(n-6)), with a particular role in the inflammatory response.

  • Drugs that act on it: 3
  • Approved: 2
  • In phases 1 to 3: 1
  • Sponsors: 1

Who is on it, and how far along

Every drug ChEMBL records acting on PTGS1, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Small molecule 3

Approved2

  • Alclofenac
  • Mofezolac

Phase 31

  • Antipyrine

Phase 20

    Phase 10

      The landscape

      Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials. All act as: Cyclooxygenase-1 inhibitor.
      AlclofenacWithdrawnApproved—Small moleculeInhibitor0
      MofezolacApproved—Small moleculeInhibitor0
      AntipyrinePhase 3OrganonSmall moleculeInhibitor3

      Open trials

      The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 3 in all, from ClinicalTrials.gov.
      Edaravone Dexborneol for Blood-Brain Barrier Repair in Acute Anterior Circulation StrokeAntipyrinePhase 4RecruitingShandong Provincial HospitalNov 12, 2026
      Efficacy and Safety Study of Ultra-early Mobile Stroke Unit Neuroprotection Combined With Revascularization for Acute Ischemic Stroke (EXCELLENT)AntipyrinePhase 4RecruitingRuijun JiAug 12, 2025
      Edaravone in the Treatment of Optic NeuritisAntipyrineNot applicableRecruitingFirst Affiliated Hospital of Guangxi Medical UniversitySep 14, 2022

      Diseases most associated with it

      Open Targets association score, 0 to 1; all associations

      Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL221, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-21. Gene name, function (UniProt P23219, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets

      Esc

      Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

      Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.